# Brunei Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Brunei HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Brunei (BRN)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $1.5B
- Products: 20
- Buyer markets: 23
- Average CAGR: +25.5%
- Global sector size: $318.2B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $202.5B | $161.0K | $73.9B | +24.0% | 12 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $28.9B | $611.8K | $17.0B | +34.4% | 12 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $20.4B | $3.6M | $8.8B | +4.2% | 5 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $20.4B | $5.9K | $8.7B | +27.1% | 6 | +0.0% |
| HS 290243 - Cyclic hydrocarbons: p-xylene | $8.5B | $966.3M | $4.6B | +93.4% | 1 | +11.3% |
| HS 290110 - Acyclic hydrocarbons: saturated | $2.0B | $2.7M | $3.8B | +81.8% | 1 | +0.3% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $7.5B | $1.6K | $3.5B | +82.5% | 1 | +0.0% |
| HS 290220 - Cyclic hydrocarbons: benzene | $4.1B | $516.2M | $2.6B | +233.0% | 1 | +12.5% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $4.9B | $10.2 | $2.5B | -10.3% | 3 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $3.4B | $3.2K | $2.2B | -13.4% | 3 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $8.4 | $2.0B | -0.5% | 1 | +0.0% |
| HS 290122 - Acyclic hydrocarbons: unsaturated, propene (propylene) | $1.6B | $2.7M | $1.8B | -25.6% | 1 | +0.1% |
| HS 290511 - Alcohols: saturated monohydric, methanol (methyl alcohol) | $3.5B | $29.0M | $1.5B | +6.2% | 2 | +0.9% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $875.7M | $1.3K | $1.3B | +148.2% | 1 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $1.7B | $0.2 | $1.3B | -31.0% | 1 | +0.0% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $669.2M | $5.5K | $1.0B | +12.1% | 1 | +0.0% |
| HS 281820 - Aluminium oxide: other than artificial corundum | $842.4M | $1.8K | $965.3M | +33.2% | 1 | +0.0% |
| HS 284440 - Radioactive elements, isotopes, compounds, n.e.c. in heading no. 2844 alloys, dispersions (including cermets), ceramic products and mixtures containing these elements, isotopes or compounds: radioactive residues | $927.2M | $25.7K | $685.1M | +15.1% | 1 | +0.0% |
| HS 284410 - Uranium: natural uranium and its compounds, alloys, dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds | $1.0B | $790.3 | $681.0M | +57.7% | 1 | +0.0% |
| HS 284390 - Inorganic or organic compounds: of precious metals (excluding gold and silver), whether or not chemically defined, amalgams of precious metals | $453.9M | $17.7 | $560.2M | -96.4% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $30.9B calculated opportunity across 7 products.
- China (CHN): $28.1B calculated opportunity across 10 products.
- Switzerland, Liechtenstein (CHE): $27.7B calculated opportunity across 1 products.
- United Kingdom (GBR): $9.1B calculated opportunity across 6 products.
- Germany (DEU): $7.2B calculated opportunity across 4 products.
- Belgium (BEL): $7.0B calculated opportunity across 1 products.
- Canada (CAN): $4.9B calculated opportunity across 2 products.
- Japan (JPN): $4.5B calculated opportunity across 2 products.
- Singapore (SGP): $4.4B calculated opportunity across 4 products.
- Malaysia (MYS): $2.8B calculated opportunity across 3 products.
- France (FRA): $2.0B calculated opportunity across 2 products.
- India (IND): $1.7B calculated opportunity across 2 products.

## Growth stars

- HS 290220: +233.0% average CAGR, $2.6B calculated opportunity.
- HS 293399: +148.2% average CAGR, $1.3B calculated opportunity.
- HS 290243: +93.4% average CAGR, $4.6B calculated opportunity.
- HS 300212: +82.5% average CAGR, $3.5B calculated opportunity.
- HS 290110: +81.8% average CAGR, $3.8B calculated opportunity.
- HS 284410: +57.7% average CAGR, $681.0M calculated opportunity.
- HS 382499: +34.4% average CAGR, $17.0B calculated opportunity.
- HS 281820: +33.2% average CAGR, $965.3M calculated opportunity.
- HS 382200: +27.1% average CAGR, $8.7B calculated opportunity.
- HS 300490: +24.0% average CAGR, $73.9B calculated opportunity.

## Diversification opportunities

- HS 300490: 12 buyer markets, $73.9B calculated opportunity.
- HS 382499: 12 buyer markets, $17.0B calculated opportunity.
- HS 382200: 6 buyer markets, $8.7B calculated opportunity.
- HS 330499: 5 buyer markets, $8.8B calculated opportunity.
- HS 300290: 3 buyer markets, $2.5B calculated opportunity.
- HS 330300: 3 buyer markets, $2.2B calculated opportunity.
- HS 290511: 2 buyer markets, $1.5B calculated opportunity.
- HS 290243: 1 buyer markets, $4.6B calculated opportunity.
- HS 290110: 1 buyer markets, $3.8B calculated opportunity.
- HS 300212: 1 buyer markets, $3.5B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.